1,631
Views
41
CrossRef citations to date
0
Altmetric
Editorial

Vitamin D, NOD2, autophagy and Crohn’s disease

, &
Pages 505-508 | Published online: 10 Jan 2014

References

  • Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer7(9), 684–700 (2007).
  • White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun.76(9), 3837–3843 (2008).
  • Tavera-Mendoza LE, White, JH. Cell defenses and the sunshine vitamin. Sci. Am.297, 62–72 (2007).
  • Holick MF. Vitamin D deficiency. N. Engl. J. Med.357(3), 266–281 (2007).
  • Lai Y, Gallo RL. Amped up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol.30(3), 131–141 (2009).
  • Wang T-T, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol.173(5), 2909–2912 (2004).
  • Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science311(5768), 1770–1773 (2006).
  • Weber G, Heilborn JD, Chamorro Jimenez CI et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Investig. Dermatol.124(5), 1080–1082 (2005).
  • Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly upregulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J.19(9), 1067–1077 (2005).
  • White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J. Steroid Biochem. Mol. Biol. DOI:10.1016/j.jsbmb.2010.03.034 (2010) (Epub ahead of print).
  • Coulombe F, Behr MA. Crohn’s disease as an immune deficiency? Lancet374(9692), 769–770 (2009).
  • Hugot J-P, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature411(6837), 599–603 (2001).
  • Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J. Biol. Chem.278(8), 5509–5512 (2003).
  • Coulombe F, Divangahi M, Veyrier F et al. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J. Exp. Med.206(8), 1709–1716 (2009).
  • Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet.39(2), 207–211 (2007).
  • Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet.39(5), 596–604 (2007).
  • Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat. Genet.39(7), 830–832 (2007).
  • Travassos LH, Carneiro LAM, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol.11(1), 55–62 (2010).
  • Cooney R, Baker J, Brain O et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med.16(1), 90–97 (2010).
  • Mizushima N, Kuma A, Kobayashi Y et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12–Apg5 conjugate. J. Cell. Sci.116(9), 1679–1688 (2003).
  • Wang T-T, Dabbas B, Laperriere D et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in Crohn disease. J. Biol. Chem.285(4), 2227–2231 (2010).
  • Fellermann K, Stange DE, Schaeffeler E et al. A chromosome 8 gene-cluster polymorphism with low human β-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet.79(3), 439–448 (2006).
  • Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal a-defensin expression. Gut53(11), 1658–1664 (2004).
  • Yuk J-M, Shin D-M, Lee H-M et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe6(3), 231–243 (2009).
  • Lapaquette P, Glasser A-L, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn’s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell. Microbiol.12(1), 99–113 (2010).
  • Feller M, Huwiler K, Stephan R et al.Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect. Dis.7(9), 607–613 (2007).
  • Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol.92(1), 60–64 (2006).
  • Koutkia P, Lu Z, Chen TC, Holick MF. Treatment of vitamin d deficiency due to Crohn’s disease with tanning bed ultraviolet B radiation. Gastroenterology121(6), 1485–1488 (2001).
  • Laverny G, Penna G, Vetrano S et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol. Lett.131(1), 49–58 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.